Case Reports
doi: 10.5414/cnp66054.
Successful therapeutic use of rituximab in refractory membranous glomerulonephritis
Affiliations
- PMID: 16878436
- DOI: 10.5414/cnp66054
Item in Clipboard
Case Reports
Successful therapeutic use of rituximab in refractory membranous glomerulonephritis
Clin Nephrol.
2006 Jul.
Abstract
We present the case of a 57-year-old man with nephrotic syndrome secondary to idiopathic membranous glomerulonephritis unsuccessfully treated with angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor antagonist (ARA), prednisone and chlorambucil. After treatment with rituximab, we observed a progressive decrease of proteinuria and normalization of serum albumin. 18 months after treatment, he remained in remission. No adverse reactions to rituximab were noted throughout follow-up.
Similar articles
-
Rituximab treatment of idiopathic membranous nephropathy.Kidney Int. 2008 Jan;73(1):117-25. doi: 10.1038/sj.ki.5002628. Epub 2007 Oct 17. Kidney Int. 2008. PMID: 17943078 Clinical Trial.
-
Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm?Clin Exp Nephrol. 2018 Feb;22(1):208-209. doi: 10.1007/s10157-017-1437-2. Epub 2017 Jun 28. Clin Exp Nephrol. 2018. PMID: 28660444 No abstract available.
-
Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient.Am J Transplant. 2006 Dec;6(12):3017-21. doi: 10.1111/j.1600-6143.2006.01544.x. Am J Transplant. 2006. PMID: 17294527
-
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.Clin J Am Soc Nephrol. 2016 Apr 7;11(4):710-20. doi: 10.2215/CJN.08500815. Epub 2015 Nov 19. Clin J Am Soc Nephrol. 2016. PMID: 26585985 Free PMC article. Review.
-
Rituximab and nephrotic syndrome: a new therapeutic hope?Nephrol Dial Transplant. 2008 Jan;23(1):11-7. doi: 10.1093/ndt/gfm683. Epub 2007 Dec 9. Nephrol Dial Transplant. 2008. PMID: 18065825 Review. No abstract available.
Cited by
-
Rituximab therapy for membranous nephropathy: a systematic review.Clin J Am Soc Nephrol. 2009 Apr;4(4):734-44. doi: 10.2215/CJN.05231008. Epub 2009 Mar 11. Clin J Am Soc Nephrol. 2009. PMID: 19279120 Free PMC article.
-
Controversies in the treatment of idiopathic membranous nephropathy.Nat Rev Nephrol. 2009 Aug;5(8):469-79. doi: 10.1038/nrneph.2009.101. Epub 2009 Jul 7. Nat Rev Nephrol. 2009. PMID: 19581908 Free PMC article. Review.
-
Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.Int Urol Nephrol. 2008;40(3):807-10. doi: 10.1007/s11255-008-9393-0. Epub 2008 May 20. Int Urol Nephrol. 2008. PMID: 18491215